1
|
Candelaria M, Cervera-Ceballos E, Meneses-García A, Avilés-Salas A, Lome-Maldonado C, Zárate-Osorno A, Ortiz-Hidalgo C, Rodríguez-Moguel L, Quiñónez-Urrego EE, Ramos-Salazar P, Romero-Guadarrama MB, Lara-Torres C, Ramírez-Aceves R, López-Navarro O, Rivas-Vera S, Díaz-Meneses IE, Estrada-Lobato E, Cervera-Ceballos J, Rojas-Marín CE, Hernández-Rodriguez JM, Pérez-López B, Gómez-Almaguer D, Altamirano-Ley J, Baz P, Valero-Saldaña LM, Navarrete-Herrera JR, Torres-Salgado FG, Solano-Murillo P, Nambo-Lucio MDJ, Rivas-Llamas R, Aquino-Salgado JL, Avila-Arreguín EV, Cortês-Esteban P, Chongo-Alfaro ML, Pérez-Ramírez ODJ, Toledano-Cuevas DV, Lobato-Mendizábal E, Martínez-Ramírez MA, Morales-Maravilla A, Sosa-Camas RE, Agreda-Vásquez GP, Camacho-Hernández A, Aguayo-González A, Espinoza-Zamora JR, Sánchez-Guerrero SA, Lozano-Zavaleta V, Selva-Pallares JE, Hernádez-Rodríguez JM, Cardiel-Silva M, Castillo-Rivera MH, Villela L, Loarca-Piña LM, Zurita-Martínez H, Graham-Casassus J, Azaola-Espinosa P, Silva-López S, Armenta-San Sebastián JA, Mijangos-Huesca F, Pérez-Osorio JE, Aldaco-Sarvide F, Castellanos G, Ramírez-Ibarguen AF, Zapata-Canto N, Labardini-Méndez JR. [National guidelines of diagnosis and treatment of the non-Hodgkin lymphoma]. Rev Invest Clin 2013; 65 Suppl 2:s5-s27. [PMID: 24459777] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
Non-Hodgkin lymphoma comprises a heterogeneous group of haematological malignancies, classified according to their clinic, anatomic-pathological features and, lately, to their molecular biomarkers. Despite the therapeutic advances, nearly half of the patients will die because of this disease. The new diagnostic tools have been the cornerstone to design recent therapy targets, which must be included in the current treatment guidelines of this sort of neoplasms by means of clinical trials and evidence-based medicine. In the face of poor diagnoses devices in most of the Mexican hospitals, we recommend the present diagnose stratification, and treatment guidelines for non-Hodgkin lymphoma, based on evidence. They include the latest and most innovative therapeutic approaches, as well as specific recommendations for hospitals with limited framework and therapy resources.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - Ramón Rivas-Llamas
- Departamento de Hematologia, Banco de Sangre y Unidad de Aféresis Hospital General de Culiacán SSA, Culiacin, Sinaloa
| | - Jorge Luis Aquino-Salgado
- Departamento de Hematologia, Banco de Sangre y Unidad de Aféresis Hospital General de Culiacán SSA, Culiacin, Sinaloa
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - Mariela Cardiel-Silva
- Centenario Hospital Miguel Hidalgo, ISSSTE Hospital General Núm. 26 RAC, Aguascalientes
| | | | - Luis Villela
- Centro Médico Zambrano Hellion de Tec Salud, Teciológico de Monterrey, Monterrey, NL
| | | | | | | | | | | | | | | | | | - Fernando Aldaco-Sarvide
- Servicio de Oncología Médica del Centro Médico Nacional 20 de Noviembre, ISSSTE, México, D.F
| | - Guillermo Castellanos
- Anatomía Patológica-Citopatología, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, IMSS
| | | | | | | |
Collapse
|